Marks, David I ;
Kirkwood, Amy A ;
Rowntree, Clare J...
Marks , D I , Kirkwood , A A , Rowntree , C J , Aguiar , M , Bailey , K E , Beaton , B , Cahalin , P , Castleton , A Z , Clifton-Hadley , L , Copland , M , Goldstone , A H , Kelly , R , Lawrie , E , Lee , S , McMillan , A K , McMullin , M F , Menne , T F , Mitchell , R J , Moorman , A V , Patel , B , Patrick , P , Smith , P , Taussig , D , Yallop , D , Alapi , K Z & Fielding , A K 2022 , ' Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial ' , The Lancet Haematology , vol. 9 , no. 4 , pp. e262-e275 . https://doi.org/10.1016/S2352-3026(22)00038-2.
,
2022
